Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Kathleen N. Moore, Michael Bookman, Jalid Sehouli, Austin Miller, Charles Anderson, Giovanni Scambia, Tashanna Myers, Cagatay Taskiran, Katina Robison, Johanna Mäenpää, Lyndsay Willmott, Nicoletta Colombo, Jessica Thomes-Pepin, Michalis Liontos, Michael A. Gold, Yolanda Garcia, Sudarshan K. Sharma, Christopher J. Darus, Carol Aghajanian, Aikou Okamoto, Xiaohua Wu, Rustem Safin, Fan Wu, Luciana Molinero, Vidya Maiya, Victor K. Khor, Yvonne G. Lin, Sandro Pignata

Open source

DOI: 10.1200/jco.21.00306
Published: 2021-06-10
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.21.00306,
  title = {Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)},
  author = {Kathleen N. Moore and Michael Bookman and Jalid Sehouli and Austin Miller and Charles Anderson and Giovanni Scambia and Tashanna Myers and Cagatay Taskiran and Katina Robison and Johanna Mäenpää and Lyndsay Willmott and Nicoletta Colombo and Jessica Thomes-Pepin and Michalis Liontos and Michael A. Gold and Yolanda Garcia and Sudarshan K. Sharma and Christopher J. Darus and Carol Aghajanian and Aikou Okamoto and Xiaohua Wu and Rustem Safin and Fan Wu and Luciana Molinero and Vidya Maiya and Victor K. Khor and Yvonne G. Lin and Sandro Pignata},
  year = {2021},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.21.00306},
  url = {https://doi.org/10.1200/jco.21.00306}
}

RIS

TY  - JOUR
TI  - Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
AU  - Kathleen N. Moore
AU  - Michael Bookman
AU  - Jalid Sehouli
AU  - Austin Miller
AU  - Charles Anderson
AU  - Giovanni Scambia
AU  - Tashanna Myers
AU  - Cagatay Taskiran
AU  - Katina Robison
AU  - Johanna Mäenpää
AU  - Lyndsay Willmott
AU  - Nicoletta Colombo
AU  - Jessica Thomes-Pepin
AU  - Michalis Liontos
AU  - Michael A. Gold
AU  - Yolanda Garcia
AU  - Sudarshan K. Sharma
AU  - Christopher J. Darus
AU  - Carol Aghajanian
AU  - Aikou Okamoto
AU  - Xiaohua Wu
AU  - Rustem Safin
AU  - Fan Wu
AU  - Luciana Molinero
AU  - Vidya Maiya
AU  - Victor K. Khor
AU  - Yvonne G. Lin
AU  - Sandro Pignata
PY  - 2021
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.21.00306
UR  - https://doi.org/10.1200/jco.21.00306
ER  -

APA

Moore, K. N., Bookman, M., Sehouli, J., Miller, A., Anderson, C., Scambia, G., Myers, T., Taskiran, C., Robison, K., Mäenpää, J., Willmott, L., Colombo, N., Thomes-Pepin, J., Liontos, M., Gold, M. A., Garcia, Y., Sharma, S. K., Darus, C. J., Aghajanian, C., Okamoto, A., Wu, X., Safin, R., Wu, F., Molinero, L., Maiya, V., Khor, V. K., Lin, Y. G., & Pignata, S. (2021). Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). Journal of Clinical Oncology. https://doi.org/10.1200/jco.21.00306

Source records

crossref · retrieved 2026-09-25T12:17:51.655Z